Annual Aggregate Cost For Select Pipeline Devices Is $53 Bil. – Callahan
This article was originally published in The Gray Sheet
Executive Summary
A federal commission to weigh cost-benefit data for new technologies, while slowing time to market entry, would ensure "equitable care" for a broader population, according to Daniel Callahan, PhD, co-founder of The Hastings Center